Moleculin Biotech (MBRX) Earnings Date, Estimates & Call Transcripts $0.92 +0.07 (+8.24%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Moleculin Biotech Earnings Summary Upcoming Q3 Earnings DateMay. 9Before Market OpensEstimatedConsensus EPS (Aug. 13) -$2.10 Actual EPS (Aug. 13) -$2.23 Missed By -$0.13 Moleculin Biotech issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -$2.23, which missed the consensus estimate of -$2.10 by $0.13. With a trailing EPS of $0.00, Moleculin Biotech's earnings are expected to grow next year, from ($7.98) to ($4.79) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings Report Quarterly Report (10-Q) Press Release (8-K)MBRX Upcoming EarningsMoleculin Biotech's Q1 2025 earnings is scheduled for Friday, May 9, 2025, with a conference call scheduled on Thursday, May 8, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Moleculin Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moleculin Biotech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMBRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads Moleculin Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.71-$0.71-$0.71Q2 20251-$0.46-$0.46-$0.46Q3 20251-$0.46-$0.46-$0.46Q4 20251-$0.46-$0.46-$0.46FY 20254($2.09)($2.09)($2.09) Remove Ads Moleculin Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/9/2025(Estimated)--------8/13/2024Q2 2024-$2.10-$2.23 -$0.13-$2.76--5/10/2024Q1 2024-$3.59-$2.02+$1.57-$2.02--11/13/2023Q3 2023-$3.15-$2.85+$0.30-$0.19--8/11/2023Q2 2023-$4.20-$3.00+$1.20-$0.20--5/11/2023Q1 2023-$3.75-$4.20 -$0.45-$0.28-- Moleculin Biotech Earnings - Frequently Asked Questions When is Moleculin Biotech's earnings date? Moleculin Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on MBRX's earnings history. Did Moleculin Biotech beat their earnings estimates last quarter? In the previous quarter, Moleculin Biotech (NASDAQ:MBRX) missed the analysts' consensus estimate of ($2.10) by $0.13 with a reported earnings per share (EPS) of ($2.23). Learn more on analysts' earnings estimate vs. MBRX's actual earnings. How much profit does Moleculin Biotech generate each year? Moleculin Biotech (NASDAQ:MBRX) has a recorded net income of -$29.77 million. MBRX has generated $0.00 earnings per share over the last four quarters. What is Moleculin Biotech's EPS forecast for next year? Moleculin Biotech's earnings are expected to grow from ($7.98) per share to ($4.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies Scilex Earnings Results Immix Biopharma Earnings Results Quince Therapeutics Earnings Results Outlook Therapeutics Earnings Results Milestone Pharmaceuticals Earnings Results Century Therapeutics Earnings Results Applied Therapeutics Earnings Results Tenaya Therapeutics Earnings Results Shattuck Labs Earnings Results Skye Bioscience Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s Next Remove Ads This page (NASDAQ:MBRX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MBRX Stock Free MBRX Stock Alerts